Europe

China’s transition from a manufacturer of generic drugs to a powerhouse of biotech innovation is redrawing the pharmaceutical landscape. Europe in particular needs to sit up and take notice.

Navigation in uncertain times calls for informed, creative leadership and a commitment to the long term, says Sir Alan Parker, Chairman of Brunswick Group.

Accelerating change, increasingly complicated issues, a wide web of stakeholders—what does transformation represent against that backdrop?

This is not a temporary change, but a profound one. By Sir Alan Parker.

Linklaters’ first female Senior Partner loves leading a firm that embraces change. Brunswick’s Kim Fletcher reports.

Everything about these critical events needs to be calculated as part of a broader corporate strategy.

The CEO-led coalition B4IG brings the force of private enterprise to the battle against inequality on many fronts, everywhere in the world. Brunswick's Ann-Kathrin Richter speaks with CEO Camille Putois on the organization’s mission.

AI will have—and is already having—a major impact on global challenges. Here’s our perspective on the implications for business across 9 key societal issues. By Jon Miller.

Seven questions every board should answer about AI.

Brunswick’s Sonal R. Patel talks about the tools of stakeholder trust with Anglo American Senior Vice Presidents James Wyatt-Tilby and Tyler Broda.

Pavita Cooper, UK Chair of the 30% Club, on the campaign’s success and the work still to be done.

Satellite-based tracking of CO2 and methane emissions represent the dawn of a new era for business transparency, says Antoine Rostand, CEO of tracking platform Kayrros.